Qube Research & Technologies Ltd purchased a new stake in Omega Healthcare Investors Inc (NYSE:OHI) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,692 shares of the real estate investment trust’s stock, valued at approximately $283,000.

Several other institutional investors have also recently modified their holdings of OHI. Coastal Investment Advisors Inc. raised its position in shares of Omega Healthcare Investors by 148.4% in the second quarter. Coastal Investment Advisors Inc. now owns 683 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 408 shares during the last quarter. Kavar Capital Partners LLC acquired a new position in shares of Omega Healthcare Investors in the second quarter valued at approximately $33,000. Reilly Financial Advisors LLC raised its position in shares of Omega Healthcare Investors by 68.1% in the first quarter. Reilly Financial Advisors LLC now owns 992 shares of the real estate investment trust’s stock valued at $38,000 after buying an additional 402 shares during the last quarter. Avestar Capital LLC raised its position in shares of Omega Healthcare Investors by 63.2% in the first quarter. Avestar Capital LLC now owns 1,286 shares of the real estate investment trust’s stock valued at $49,000 after buying an additional 498 shares during the last quarter. Finally, Gradient Investments LLC raised its position in shares of Omega Healthcare Investors by 54.5% in the second quarter. Gradient Investments LLC now owns 1,326 shares of the real estate investment trust’s stock valued at $49,000 after buying an additional 468 shares during the last quarter. Institutional investors and hedge funds own 66.86% of the company’s stock.

Omega Healthcare Investors stock traded up $0.13 during trading on Wednesday, reaching $39.32. The company had a trading volume of 127,440 shares, compared to its average volume of 1,555,662. Omega Healthcare Investors Inc has a 12-month low of $31.69 and a 12-month high of $40.30. The stock’s 50 day moving average price is $37.42 and its two-hundred day moving average price is $36.85. The firm has a market capitalization of $8.47 billion, a price-to-earnings ratio of 12.94, a PEG ratio of 5.16 and a beta of 0.42. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.78 and a current ratio of 2.78.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.34 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.39). Omega Healthcare Investors had a net margin of 29.38% and a return on equity of 6.79%. The company had revenue of $191.81 million during the quarter, compared to analysts’ expectations of $190.46 million. During the same quarter in the previous year, the firm posted $0.75 earnings per share. Omega Healthcare Investors’s revenue for the quarter was down .5% compared to the same quarter last year. As a group, research analysts expect that Omega Healthcare Investors Inc will post 2.95 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Wednesday, July 31st were issued a $0.66 dividend. The ex-dividend date was Tuesday, July 30th. This represents a $2.64 dividend on an annualized basis and a yield of 6.71%. Omega Healthcare Investors’s payout ratio is 86.84%.

In related news, CFO Robert O. Stephenson sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $39.00, for a total value of $390,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO C Taylor Pickett sold 5,500 shares of the business’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $38.00, for a total transaction of $209,000.00. Following the completion of the sale, the chief executive officer now owns 227,933 shares of the company’s stock, valued at $8,661,454. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 85,500 shares of company stock valued at $3,259,000. 1.16% of the stock is owned by insiders.

A number of equities analysts have recently weighed in on OHI shares. Zacks Investment Research lowered shares of Omega Healthcare Investors from a “buy” rating to a “hold” rating in a research report on Wednesday. Raymond James raised shares of Omega Healthcare Investors from an “outperform” rating to a “strong-buy” rating and boosted their price objective for the company from $40.00 to $42.00 in a research report on Thursday, August 8th. Six investment analysts have rated the stock with a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $38.77.

Omega Healthcare Investors Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Read More: What is a Buy-Side Analyst?

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors Inc (NYSE:OHI).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.